IBIO-610

N/A

Report date: 2026/03/31 20:00:21

Base Information

Drug NameIBIO-610
Drug Alias NameIBIO-610
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Inhibin beta E chain
TargetsInhibin beta E chain
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesIbio Inc
China Registration ClassN/A

Develop Information

Active CompaniesIbio Inc
Inactive CompaniesN/A
Active IndicationsObesity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A